A CMS guide to the new medicare part D overutilization policies has takeaways for pharmacists.
Jeffery Fudin, PHARMD, DAIPM, FCCP, FASHP, FFSMB
Advertisement
Articles by Jeffery Fudin, PHARMD, DAIPM, FCCP, FASHP, FFSMB
Advertisement
Latest Updated Articles
Carefully Assess Opioid Drug Interaction RisksPublished: February 20th 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Lynkuet Access Program Aims to Help Women Save on Neurokinin-Targeted Therapy
2
Fall 2025 Quiz: Test Your Pharmacy Knowledge!
3
FDA Approves Blenrep for Treatment of Relapsed or Refractory Multiple Myeloma
4
Hormone Therapy Use, Understanding, and Perceptions Have Positively Shifted From 2021 to 2025
5
